𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas

✍ Scribed by Domagoj Vucic; Henning R. Stennicke; Maria Teresa Pisabarro; Guy S. Salvesen; Vishva M. Dixit

Book ID
114317932
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
373 KB
Volume
10
Category
Article
ISSN
0960-9822

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The Bcl-xL inhibitor of apoptosis is pre
The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma
✍ Natasa VasiljeviΔ‡; Kristin Andersson; Kaj Bjelkenkrantz; Christer KjellstrΓΆm; He πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 281 KB

## Abstract Keratoacanthoma (KA) is difficult to histologically distinguish from squamous cell carcinoma (SCC). Therefore, although KA is a benign self‐resolving skin lesion, KA is commonly treated as SCC. Biomarkers to distinguish KA and SCC would thus be desirable. In search for specific markers,